What are vaccine adjuvants?

Vaccine adjuvants are substances added to vaccines to enhance the body's immune response to the antigen, making the vaccine more effective.

How big is the Vaccine Adjuvants Market?

The global Vaccine Adjuvants Market size was estimated at USD 1,134.7 Million in 2022 and is expected to reach USD 3,933.7 Million in 2032.

What is the Vaccine Adjuvants Market growth?

The global Vaccine Adjuvants Market is expected to grow at a compound annual growth rate of 13.6%. From 2023 To 2032

Who are the key companies/players in the Vaccine Adjuvants Market?

Some of the key players in the Vaccine Adjuvants Markets are Merck KGaA, Dynavax Technologies Corporation, Croda International Plc, Novavax, Inc., CSL Limited, AstraZeneca plc, MPV Technologies LLC, Adjuvance Technologies, Inc., SPI Pharma, Agenus Inc., Astellas Pharma, Inc., CureVac N.V., Sanofi S.A., GlaxoSmithKline plc, OZ Biosciences, Vaxine Pty Ltd, Merck & Co, Inc., Phibro Animal Health Corporation, Brenntag Biosector, Brenntag SE, Other Key Players

Why are vaccine adjuvants used?

Adjuvants help vaccines work better by stimulating a stronger and longer-lasting immune response, reducing the required vaccine dosage.

Are vaccine adjuvants safe?

Yes, adjuvants used in vaccines are rigorously tested for safety and efficacy before they are approved for use.

Global Vaccine Adjuvants Market by Product Type (Adjuvant Emulsion, Particulate Adjuvants, and Pathogen Components), By Route of Administration (Oral, Subcutaneous, Intradermal, Intramuscular, and Intranasal), By Application (Research and Commercial), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Oct 2023
Report ID: 21362
Number of Pages: 344
Format:

- Merck KGaA Company Profile
- Dynavax Technologies Corporation
- Croda International Plc
- Novavax, Inc.
- CSL Limited
- AstraZeneca Plc Company Profile
- MPV Technologies LLC
- Adjuvance Technologies, Inc.
- SPI Pharma
- Agenus Inc.
- Astellas Pharma, Inc.
- CureVac N.V.
- Sanofi S.A.
- GlaxoSmithKline plc
- OZ Biosciences
- Vaxine Pty Ltd
- Merck & Co, Inc.
- Phibro Animal Health Corporation
- Brenntag Biosector
- Brenntag SE
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 21362
Published Date Oct 2023
Rating
- ★★★★★
  
  ★★★★★
- (70)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)